HTG Molecular Diagnostics, Inc. Forms 3, 4 and 5: Other
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 1 rows, 1 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2017-10-26: Reporting owner QIAGEN NV; Form 4; Security Common Stock; Transaction P Open market or private purchase of non-derivative or derivative security.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2017-10-26 | QIAGEN NV 10% Owner | 4 | Common Stock Derivative · Indirect · Held through QIAGEN North America Holdings, Inc., a wholly owned subsidiary | P Open market or private purchase of non-derivative or derivative security | +753,012 753,012 owned after | $3.98 exercise price | 2017-11-07 |